March 14 (Reuters) - Correvio Pharma Corp CORV.TO :
* CORREVIO ANNOUNCES AT THE MARKET OFFERING
* CORREVIO PHARMA CORP - ENTERED INTO AT MARKET SALES ISSUANCE AGREEMENT DATED MARCH 13, 2019 WITH CANTOR FITZGERALD & CO.
* CORREVIO PHARMA CORP - UNDER AGREEMENT, CO MAY SELL COMMON SHARES OF UP TO $50 MILLION, SUBJECT TO LIMIT OF $12 MILLION UNDER ATM PROSPECTUS SUPPLEMENT
* CORREVIO PHARMA - PLANS TO USE NET PROCEEDS FOR PREPARATIONS FOR FUTURE PRODUCT LAUNCHES, INCLUDING EXPECTED RESUBMISSION OF AN NDA FOR BRINAVESS